Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zulfiya Syunyaeva

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Innere Medizin (Heidelberg, Germany)|May 7, 2024
[Cystic fibrosis in childhood and adulthood]Zulfiya Syunyaeva, Marcus A Mall, Mirjam Stahl
AME Case Reports|November 16, 2019
Excellent platinum dependent response to chemotherapy after relapse under TKI treatment in NSCLC with sensitizing EGFR mutations and no detectable resistance mutations: three case studiesDiego Kauffmann-Guerrero, Zulfiya Syunyaeva, Kathrin Kahnert, et al.
Chest|October 10, 2020
ResponseElke C Sattler, Zulfiya Syunyaeva, Ulrich Mansmann, et al.
Chest|January 21, 2020
Genetic Risk Factors for Spontaneous Pneumothorax in Birt-Hogg-Dubé SyndromeElke C Sattler, Zulfiya Syunyaeva, Ulrich Mansmann, et al.
Eclinicalmedicine|July 25, 2022
Delayed diagnosis of Birt-Hogg-Dubé syndrome might be aggravated by gender biasOrtrud K Steinlein, Marlene Reithmair, Zulfiya Syunyaeva, et al.
Frontiers in Medicine|November 29, 2023
Risk of pneumothorax in Birt-Hogg-Dubé syndrome during pregnancy and birthOrtrud K Steinlein, Marlene Reithmair, Zulfiya Syunyaeva, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|December 4, 2024
Changing profile of bacterial infection and microbiome in cystic fibrosis: when to use antibiotics in the era of CFTR-modulator therapyJustyna Milczewska, Zulfiya Syunyaeva, Aleksandra Żabińska-Jaroń, et al.
Oncology Research and Treatment|August 8, 2018
Pretherapeutic Inflammation Predicts Febrile Neutropenia and Reduced Progression-Free Survival after First-Line Chemotherapy in SCLCDiego Kauffmann-Guerrero, Kathrin Kahnert, Zulfiya Syunyaeva, et al.
Respiration; International Review of Thoracic Diseases|April 6, 2018
Dermal Filler Injections Mimic Tumor Activity during Immune Checkpoint InhibitionZulfiya Syunyaeva, Kathrin Kahnert, Diego Kauffmann-Guerrero, et al.
European Journal of Cancer (Oxford, England : 1990)|May 17, 2021
Colorectal cancer risk in families with Birt-Hogg-Dubé syndrome increasedElke C Sattler, Zulfiya Syunyaeva, Marlene Reithmair, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Innere Medizin (Heidelberg, Germany)|May 7, 2024
[Cystic fibrosis in childhood and adulthood]Zulfiya Syunyaeva, Marcus A Mall, Mirjam Stahl
AME Case Reports|November 16, 2019
Excellent platinum dependent response to chemotherapy after relapse under TKI treatment in NSCLC with sensitizing EGFR mutations and no detectable resistance mutations: three case studiesDiego Kauffmann-Guerrero, Zulfiya Syunyaeva, Kathrin Kahnert, et al.
Chest|October 10, 2020
ResponseElke C Sattler, Zulfiya Syunyaeva, Ulrich Mansmann, et al.
Chest|January 21, 2020
Genetic Risk Factors for Spontaneous Pneumothorax in Birt-Hogg-Dubé SyndromeElke C Sattler, Zulfiya Syunyaeva, Ulrich Mansmann, et al.
Eclinicalmedicine|July 25, 2022
Delayed diagnosis of Birt-Hogg-Dubé syndrome might be aggravated by gender biasOrtrud K Steinlein, Marlene Reithmair, Zulfiya Syunyaeva, et al.
Frontiers in Medicine|November 29, 2023
Risk of pneumothorax in Birt-Hogg-Dubé syndrome during pregnancy and birthOrtrud K Steinlein, Marlene Reithmair, Zulfiya Syunyaeva, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|December 4, 2024
Changing profile of bacterial infection and microbiome in cystic fibrosis: when to use antibiotics in the era of CFTR-modulator therapyJustyna Milczewska, Zulfiya Syunyaeva, Aleksandra Żabińska-Jaroń, et al.
Oncology Research and Treatment|August 8, 2018
Pretherapeutic Inflammation Predicts Febrile Neutropenia and Reduced Progression-Free Survival after First-Line Chemotherapy in SCLCDiego Kauffmann-Guerrero, Kathrin Kahnert, Zulfiya Syunyaeva, et al.
Respiration; International Review of Thoracic Diseases|April 6, 2018
Dermal Filler Injections Mimic Tumor Activity during Immune Checkpoint InhibitionZulfiya Syunyaeva, Kathrin Kahnert, Diego Kauffmann-Guerrero, et al.
European Journal of Cancer (Oxford, England : 1990)|May 17, 2021
Colorectal cancer risk in families with Birt-Hogg-Dubé syndrome increasedElke C Sattler, Zulfiya Syunyaeva, Marlene Reithmair, et al.
Pageof 3